(a) In this section, “health care practitioner” means a person who is licensed, certified, or otherwise authorized under this article to provide health care services in the ordinary course of business or practice of a profession.
(b) The Department shall:
(1) Identify, in consultation with stakeholders who wish to participate, up–to–date, evidence–based, written information relating to attention–deficit/hyperactivity disorder that:
(i) Has been reviewed by medical experts, mental health care practitioners, and national and local organizations specializing in the provision of services for the treatment of attention–deficit/hyperactivity disorder;
(ii) Is designed for use by health care practitioners and the families of children and adolescents who are diagnosed with attention–deficit/hyperactivity disorder;
(iii) Is culturally and linguistically appropriate for potential recipients of the information; and
(iv) Includes:
1. Treatment options for attention–deficit/hyperactivity disorder, including medication usage, behavioral health services, and nonpharmacological intervention strategies; and
2. Contact information for national and local education programs and support services; and
(2) Post the information identified by the Department under item (1) of this subsection in printable form on the Department’s Web site that may be accessed by health care practitioners engaged in treating children and adolescents for attention–deficit/hyperactivity disorder.